SCHEMBL15564491

SCHEMBL15564491

Cc1ccc2[nH]c(=O)c(C(=O)CNC(=O)O)cc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.54
ALDH1A1 P00352 10/20 0.53
KDM4E B2RXH2 9/20 0.53
HSD17B10 Q99714 6/20 0.53
PIN1 Q13526 1/20 0.50
HPGD P15428 5/20 0.49
MAPT P10636 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
GAA P10253 2/20 0.48
ALOX15 P16050 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
HTT P42858 1/20 0.47
POLB P06746 3/20 0.47
TP53 P04637 1/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4649667 0.82 DAO (0.52) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL10969986 0.82 KDM4E (0.66) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL1366351 0.81 DAO (0.65) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL12082628 0.78 ALDH1A1 (0.61) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL22223088 0.75 DAO (0.58) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL4649161 0.75 ALDH1A1 (0.50) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL16767844 0.71 DAO (1.00) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL16381141 0.70 DAO (0.68) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL10330642 0.70 DAO (0.63) DAOALDH1A1KDM4EHSD17B10PIN1
SCHEMBL10969990 0.70 DAO (0.58) DAOALDH1A1KDM4EHSD17B10PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2882724-A1 COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC IRBM - Science Park S.p.A. (IT) 2015-06-17 EP disclosed
WO-2014023754-A1 COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC IRBM - SCIENCE PARK S.P.A. (IT) 2014-02-13 WO disclosed